Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza (Q71120792)
Jump to navigation
Jump to search
scientific article published on 01 June 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza |
scientific article published on 01 June 1996 |
Statements
Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group (English)
R B Belshe
W C Gruber
J C King
J J Treanor
P A Piedra
P F Wright
G W Reed